Opening Plenary Showcases Molecular Advances Leading to Big Revolutions in Cancer Research
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
This quarter’s new tools and strategies for cancer research included molecular jackhammers and biobots that crawl.
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
Metastasis is defined as the spreading of cancer cells from the place where they first formed to another part...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
The American Association for Cancer Research (AACR) recently appointed Chi Van Dang, MD, PhD, as the new editor-in-chief of...
Yesterday, the American Association for Cancer Research (AACR) joined the American Cancer Society (ACS), the American Society of Clinical...